BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 24938303)

  • 1. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
    Freund KM; Battaglia TA; Calhoun E; Darnell JS; Dudley DJ; Fiscella K; Hare ML; LaVerda N; Lee JH; Levine P; Murray DM; Patierno SR; Raich PC; Roetzheim RG; Simon M; Snyder FR; Warren-Mears V; Whitley EM; Winters P; Young GS; Paskett ED;
    J Natl Cancer Inst; 2014 Jun; 106(6):dju115. PubMed ID: 24938303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program.
    Ko NY; Snyder FR; Raich PC; Paskett ED; Dudley DJ; Lee JH; Levine PH; Freund KM
    Cancer; 2016 Sep; 122(17):2715-22. PubMed ID: 27227342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis.
    Battaglia TA; Darnell JS; Ko N; Snyder F; Paskett ED; Wells KJ; Whitley EM; Griggs JJ; Karnad A; Young H; Warren-Mears V; Simon MA; Calhoun E
    Breast Cancer Res Treat; 2016 Aug; 158(3):523-34. PubMed ID: 27432417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of patient and navigator race and language concordance on care after cancer screening abnormalities.
    Charlot M; Santana MC; Chen CA; Bak S; Heeren TC; Battaglia TA; Egan AP; Kalish R; Freund KM
    Cancer; 2015 May; 121(9):1477-83. PubMed ID: 25565151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.
    Ramachandran A; Freund KM; Bak SM; Heeren TC; Chen CA; Battaglia TA
    J Womens Health (Larchmt); 2015 Jan; 24(1):30-6. PubMed ID: 25513858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.
    Raich PC; Whitley EM; Thorland W; Valverde P; Fairclough D;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1629-38. PubMed ID: 23045537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing Urban Myths About Cancer With Community Wisdom: Putting a Finger on Cancer Disparities.
    Vapiwala N
    JAMA Oncol; 2016 Aug; 2(8):996-8. PubMed ID: 27196799
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparities.
    Goldie SJ; Daniels N
    J Natl Cancer Inst; 2011 Sep; 103(18):1373-86. PubMed ID: 21900120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.
    Katz ML; Young GS; Reiter PL; Battaglia TA; Wells KJ; Sanders M; Simon M; Dudley DJ; Patierno SR; Paskett ED
    Womens Health Issues; 2014; 24(1):e155-62. PubMed ID: 24439942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
    Atlas SJ; Tosteson ANA; Wright A; Orav EJ; Burdick TE; Zhao W; Hort SJ; Wint AJ; Smith RE; Chang FY; Aman DG; Thillaiyapillai M; Diamond CJ; Zhou L; Haas JS
    JAMA; 2023 Oct; 330(14):1348-1358. PubMed ID: 37815566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating research into practice: Protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative.
    Battaglia TA; Freund KM; Haas JS; Casanova N; Bak S; Cabral H; Freedman RA; White KB; Lemon SC;
    Contemp Clin Trials; 2020 Jun; 93():106007. PubMed ID: 32305457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
    Markossian TW; Darnell JS; Calhoun EA
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient barriers to follow-up care for breast and cervical cancer abnormalities.
    Tejeda S; Darnell JS; Cho YI; Stolley MR; Markossian TW; Calhoun EA
    J Womens Health (Larchmt); 2013 Jun; 22(6):507-17. PubMed ID: 23672296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.
    Bensink ME; Ramsey SD; Battaglia T; Fiscella K; Hurd TC; McKoy JM; Patierno SR; Raich PC; Seiber EE; Warren-Mears V; Whitley E; Paskett ED; Mandelblatt S;
    Cancer; 2014 Feb; 120(4):570-8. PubMed ID: 24166217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to Diagnostic Evaluation After Mammographic Screening in an Urban Setting.
    Oppong BA; Dash C; Coleman T; Torres T; Adams-Campbell LL
    J Womens Health (Larchmt); 2016 Dec; 25(12):1225-1230. PubMed ID: 27182625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
    Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?
    Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
    Cancer; 2016 Nov; 122(21):3371-3377. PubMed ID: 27434225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.